<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/'><id>tag:blogger.com,1999:blog-28450497.post1840599158199332672..comments</id><updated>2009-10-07T22:36:17.948-04:00</updated><category term='Channel Management'/><category term='Supply Chain Technology'/><category term='Blog Administration'/><category term='Importation'/><category term='Health Care Policy'/><category term='Group Purchasing Organizations (GPOs)'/><category term='Drug Shortages'/><category term='Industry Trends'/><category term='Fun Stuff'/><category term='PBMs'/><category term='Wholesalers'/><category term='Pharmacy Economics'/><category term='Pharmacy'/><category term='Supply Chain Humor'/><category term='Drug Counterfeiting'/><category term='Health Care Reform'/><category term='Pharmacogenomics'/><category term='Pedigree'/><category term='Specialty Drugs'/><category term='Medicare Part D'/><category term='Average Sales Price (ASP)'/><category term='Accountable Care Organizations (ACOs)'/><category term='Generic Drugs'/><category term='Guest Post'/><category term='Marketing'/><category term='RFID'/><category term='Average Acquisition Cost (AAC)'/><category term='International Drug Channels'/><category term='Enforcement'/><category term='Costs/Reimbursement'/><category term='Average Manufacturer Price (AMP)'/><category term='Mergers and Acquisitions'/><title type='text'>Comments on Drug Channels: A Peek at Drug Wholesalers' Economics</title><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://www.drugchannels.net/feeds/1840599158199332672/comments/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/1840599158199332672/comments/default'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/10/peek-at-drug-wholesalers-economics.html'/><author><name>Adam J. Fein, Ph.D.</name><uri>http://www.blogger.com/profile/12217252282643255442</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='25' height='32' src='http://4.bp.blogspot.com/_jauTfEtde80/TTnq9WCPzYI/AAAAAAAAAAM/VNKwcn8y_BA/s220/AdamJFein-DrugChannels.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>4</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-28450497.post-6020496461925134999</id><published>2009-10-07T22:31:42.640-04:00</published><updated>2009-10-07T22:31:42.640-04:00</updated><title type='text'>Actually, the 2% goes way back further than charge...</title><content type='html'>Actually, the 2% goes way back further than chargebacks.  Chargebacks have never played a part in this &amp;quot;gift&amp;quot;.  In the past (OK, way back) wholesalers made an upcharge on sales, even chargeback sales.  In fact, when contracting started manufacturers sold direct (no chargeback mechanism).  Wholesalers ASKED to be let in on the sales and came up with the idea for chargebacks.  -A</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/1840599158199332672/comments/default/6020496461925134999'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/1840599158199332672/comments/default/6020496461925134999'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/10/peek-at-drug-wholesalers-economics.html?showComment=1254969102640#c6020496461925134999' title=''/><author><name>Al Godley</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/10/peek-at-drug-wholesalers-economics.html' ref='tag:blogger.com,1999:blog-28450497.post-1840599158199332672' source='http://www.blogger.com/feeds/28450497/posts/default/1840599158199332672' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-1319408704'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-238621415015282972</id><published>2009-10-07T11:18:47.032-04:00</published><updated>2009-10-07T11:18:47.032-04:00</updated><title type='text'>2% is a historical gift indeed.  The origin, I bel...</title><content type='html'>2% is a historical gift indeed.  The origin, I believe, goes back to manufacturers trying to respond to some of the wholesalers concerns around costs involved with handling chargebacks, etc.  Unfortunately, they used much of this guaranteed profit to drop their pricing downstream, in the quest for top-line revenue and share growth.  The same continues to occur in the FFS world.</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/1840599158199332672/comments/default/238621415015282972'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/1840599158199332672/comments/default/238621415015282972'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/10/peek-at-drug-wholesalers-economics.html?showComment=1254928727032#c238621415015282972' title=''/><author><name>Anonymous</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/10/peek-at-drug-wholesalers-economics.html' ref='tag:blogger.com,1999:blog-28450497.post-1840599158199332672' source='http://www.blogger.com/feeds/28450497/posts/default/1840599158199332672' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-547220984'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-6210654685951506779</id><published>2009-10-07T09:54:17.070-04:00</published><updated>2009-10-07T09:54:17.070-04:00</updated><title type='text'>I like the term prompt-pay terms...2% 30, net 31. ...</title><content type='html'>I like the term prompt-pay terms...2% 30, net 31.  Is one day really prompt pay?  I was discussing this with a Trade Exec once and asked about removing the 2% and rolling it all into the IMA/FFS.  He was mortified and refused to discuss it because &amp;quot;the wholesalers have already given this away to their customers&amp;quot;.  I found that very interesting.  2% is a big gift and I&amp;#39;d think a manufacturer should want to get more for that than just one day of faster payments.  -A</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/1840599158199332672/comments/default/6210654685951506779'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/1840599158199332672/comments/default/6210654685951506779'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/10/peek-at-drug-wholesalers-economics.html?showComment=1254923657070#c6210654685951506779' title=''/><author><name>Anonymous</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/10/peek-at-drug-wholesalers-economics.html' ref='tag:blogger.com,1999:blog-28450497.post-1840599158199332672' source='http://www.blogger.com/feeds/28450497/posts/default/1840599158199332672' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-1319408704'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-6150309065795195587</id><published>2009-10-07T09:03:34.965-04:00</published><updated>2009-10-07T09:03:34.965-04:00</updated><title type='text'>Can I presume you got a free Obama chia also?</title><content type='html'>Can I presume you got a free Obama chia also?</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/1840599158199332672/comments/default/6150309065795195587'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/1840599158199332672/comments/default/6150309065795195587'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/10/peek-at-drug-wholesalers-economics.html?showComment=1254920614965#c6150309065795195587' title=''/><author><name>Anonymous</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/10/peek-at-drug-wholesalers-economics.html' ref='tag:blogger.com,1999:blog-28450497.post-1840599158199332672' source='http://www.blogger.com/feeds/28450497/posts/default/1840599158199332672' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-2124435797'/></entry></feed>
